Our results indicate that while data from AK can provide some insights into keloids, future studies should directly obtain spatial transcriptomic data for keloids to more accurately explore the anti‐fibrotic mechanisms of IGFBP2+ fibroblasts and leverage this cell subpopulation to develop novel therapeutic strategies. The gene discussed is IGFBP2; the disease is keloid.